SCHEMBL6380456

SCHEMBL6380456

O=C(O)C(Cc1ccc(OCCn2ccc3ccccc32)cc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.57
FFAR1 O14842 1/20 0.57
PPARD Q03181 5/20 0.52
PPARA Q07869 5/20 0.52
MAPK1 P28482 1/20 0.51
LDHA P00338 1/20 0.47
MCL1 Q07820 3/20 0.47
LMNA P02545 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
HSD17B10 Q99714 1/20 0.45
CDK4 P11802 1/20 0.45
CCND1 P24385 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6536655 0.91 PPARG (0.55) PPARGFFAR1PPARDPPARAMAPK1
SCHEMBL6383661 0.89 PPARG (0.63) PPARGFFAR1PPARDPPARAMAPK1
SCHEMBL6381304 0.88 PPARG (0.53) PPARGFFAR1PPARDPPARAMAPK1
SCHEMBL6485383 0.84 LTA4H (0.46) PPARGFFAR1PPARDPPARALDHA
SCHEMBL6380437 0.83 PPARG (0.53) PPARGFFAR1PPARDPPARAMAPK1
SCHEMBL6477969 0.82 MTNR1A (0.48) PPARGFFAR1PPARDPPARALDHA
SCHEMBL6379224 0.82 FFAR1 (0.51) PPARGFFAR1MAPK1MCL1LMNA
SCHEMBL6380447 0.80 FFAR1 (0.56) PPARGFFAR1MAPK1MCL1LMNA
SCHEMBL6379227 0.80 FFAR1 (0.56) PPARGFFAR1MAPK1MCL1LMNA
SCHEMBL6380188 0.80 PPARG (0.52) PPARGFFAR1PPARDPPARAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-02-10 US claimed
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-02-10 US disclosed
EP-1465858-A2 PHENY(ALKYL)CARBOXYLIC ACID DERIVATIVES AND DIONIC PHENYLALKYLHETEROCYCLIC DERIVATIVES AND THEIR USE AS MEDICINES WITH SERUM GLUCOSE AND/OR SERUM LIPID LOWERING ACTIVITY Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2004-10-13 EP disclosed
WO-2003059864-A2 PHENY(ALKYL)CARBOXYLIC ACID DERIVATIVES AND DIONIC PHENYLALKYLHETEROCYCLIC DERIVATIVES AND THEIR USE AS MEDICINES WITH SERUM GLUCOSE AND/OR SERUM LIPID LOWERING ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity LIPC, CPT1A, GPR119 PPARG 127/4885FFAR1 63/4885PPARD 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.